159316 创新药E
午间休市 05-27 11:30:00
资讯
新帖
简况
【ETF动向】5月26日港股通创新药ETF汇添富基金跌1.07%，份额减少3.79亿份
中金财经 · 08:34
【ETF动向】5月26日港股通创新药ETF汇添富基金跌1.07%，份额减少3.79亿份
【ETF动向】5月26日港股通创新药ETF汇添富基金跌1.07%，份额减少3.79亿份
证券之星 · 08:02
【ETF动向】5月26日港股通创新药ETF汇添富基金跌1.07%，份额减少3.79亿份
【ETF动向】5月25日创新药ETF银华基金跌1.28%，份额减少1.12亿份
证券之星 · 05-26 08:02
【ETF动向】5月25日创新药ETF银华基金跌1.28%，份额减少1.12亿份
【ETF动向】5月21日港股通创新药ETF汇添富基金涨2.24%，份额减少1.88亿份
中金财经 · 05-22
【ETF动向】5月21日港股通创新药ETF汇添富基金涨2.24%，份额减少1.88亿份
【ETF动向】5月21日港股通创新药ETF汇添富基金涨2.24%，份额减少1.88亿份
证券之星 · 05-22
【ETF动向】5月21日港股通创新药ETF汇添富基金涨2.24%，份额减少1.88亿份
【ETF动向】5月20日港股通创新药ETF汇添富基金跌0.93%，份额减少2.82亿份
证券之星 · 05-21
【ETF动向】5月20日港股通创新药ETF汇添富基金跌0.93%，份额减少2.82亿份
创新药继续筑底，华宝基金药ETF、港股通创新药ETF再探历史新低！“抄底”资金狂涌，520880近10日吸金7.7亿
新浪基金 · 05-20
创新药继续筑底，华宝基金药ETF、港股通创新药ETF再探历史新低！“抄底”资金狂涌，520880近10日吸金7.7亿
【ETF动向】5月19日港股通创新药ETF汇添富基金跌0.07%，份额减少3.08亿份
证券之星 · 05-20
【ETF动向】5月19日港股通创新药ETF汇添富基金跌0.07%，份额减少3.08亿份
【ETF动向】5月18日港股通创新药ETF汇添富基金跌2.64%，份额减少1.29亿份
证券之星 · 05-19
【ETF动向】5月18日港股通创新药ETF汇添富基金跌2.64%，份额减少1.29亿份
医药赛道震荡调整，资金逆势布局，港股通创新药ETF易方达（159316）全天净申购超1亿份
证券之星 · 05-15
医药赛道震荡调整，资金逆势布局，港股通创新药ETF易方达（159316）全天净申购超1亿份
创新药板块震荡下挫，港股通创新药ETF易方达（159316）逆势获5000万份净申购
证券之星 · 05-13
创新药板块震荡下挫，港股通创新药ETF易方达（159316）逆势获5000万份净申购
创新药赛道走势分化，港股通创新药ETF易方达（159316）全天净申购超1亿份
证券之星 · 04-22
创新药赛道走势分化，港股通创新药ETF易方达（159316）全天净申购超1亿份
创新药赛道大幅回调，港股通创新药ETF易方达（159316）半日净申购近8000万份
证券之星 · 04-17
创新药赛道大幅回调，港股通创新药ETF易方达（159316）半日净申购近8000万份
创新药赛道低位整理，港股通创新药ETF易方达（159316）今日净申购达3400万份
证券之星 · 04-13
创新药赛道低位整理，港股通创新药ETF易方达（159316）今日净申购达3400万份
创新药赛道小幅反弹，港股通创新药ETF易方达（159316）今日净申购达1700万份
证券之星 · 04-10
创新药赛道小幅反弹，港股通创新药ETF易方达（159316）今日净申购达1700万份
创新药赛道早盘下挫，港股通创新药ETF易方达（159316）逆势获近3000万份净申购
证券之星 · 04-09
创新药赛道早盘下挫，港股通创新药ETF易方达（159316）逆势获近3000万份净申购
医药板块周线回调，关注港股通创新药ETF易方达（159316）、创新药ETF易方达（516080）等产品布局机会
证券之星 · 03-13
医药板块周线回调，关注港股通创新药ETF易方达（159316）、创新药ETF易方达（516080）等产品布局机会
加载更多
公司概况
公司名称：
--
所属市场：
上市日期：
--
主营业务：
发行价格：
--
{"stockData":{"symbol":"159316","market":"SZ","secType":"STK","nameCN":"创新药E","latestPrice":1.092,"timestamp":1779854430000,"preClose":1.116,"halted":0,"volume":277969425,"delay":0,"changeRate":-0.0215,"floatShares":0,"shares":0,"eps":0,"marketStatus":"午间休市","change":-0.024,"latestTime":"05-27 11:30:00","open":1.113,"high":1.114,"low":1.091,"amount":306000000,"amplitude":0.0206,"askPrice":1.093,"askSize":8036,"bidPrice":1.091,"bidSize":6224,"shortable":0,"etf":1,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1779858000000},"marketStatusCode":3,"adr":0,"adjPreClose":1.116,"symbolType":"fund","openAndCloseTimeList":[[1779845400000,1779852600000],[1779858000000,1779865200000]],"highLimit":1.228,"lowLimit":1.004,"ibTradeSell":false,"ibTradeBuySell":false,"isCdr":false,"pbRate":0,"committee":0.515785,"marketValue":0,"turnoverRate":0,"status":1,"floatMarketCap":0},"requestUrl":"/m/hq/s/159316","defaultTab":"news","newsList":[{"id":"2638210955","title":"【ETF动向】5月26日港股通创新药ETF汇添富基金跌1.07%，份额减少3.79亿份","url":"https://stock-news.laohu8.com/highlight/detail?id=2638210955","media":"中金财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2638210955?lang=zh_cn&edition=full","pubTime":"2026-05-27 08:34","pubTimestamp":1779842064,"startTime":"0","endTime":"0","summary":"证券之星消息，5月26日，港股通创新药ETF汇添富基金(159570)跌1.07%，成交额24.39亿元。当日份额减少了3.79亿份，最新份额为181.92亿份，近20个交易日份额减少6.56亿份。当日资金净流出10.65亿元(资金流向是当日计算的资产净值和上一交易日计算的资产净值相减得出的)，最新资产净值计算值为254.25亿元。港股通创新药ETF汇添富基金跟踪标的为国证港股通创新药指数，成立(2023-12-28)以来超额回报为-3.88%，近一个月超额回报为1.29%，管理人为汇添富基金公司，基金经理为乐无穹。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushiyaowen/20260527/32256845.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["VXUS","FDN","BK4588","BK4550","159316","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638529437","title":"【ETF动向】5月26日港股通创新药ETF汇添富基金跌1.07%，份额减少3.79亿份","url":"https://stock-news.laohu8.com/highlight/detail?id=2638529437","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2638529437?lang=zh_cn&edition=full","pubTime":"2026-05-27 08:02","pubTimestamp":1779840154,"startTime":"0","endTime":"0","summary":"证券之星消息，5月26日，港股通创新药ETF汇添富基金（159570）跌1.07%，成交额24.39亿元。当日份额减少了3.79亿份，最新份额为181.92亿份，近20个交易日份额减少6.56亿份。当日资金净流出10.65亿元（资金流向是当日计算的资产净值和上一交易日计算的资产净值相减得出的），最新资产净值计算值为254.25亿元。港股通创新药ETF汇添富基金跟踪标的为国证港股通创新药指数，成立（2023-12-28）以来超额回报为-3.88%，近一个月超额回报为1.29%，管理人为汇添富基金公司，基金经理为乐无穹。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026052700008260.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["159316"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638563758","title":"【ETF动向】5月25日创新药ETF银华基金跌1.28%，份额减少1.12亿份","url":"https://stock-news.laohu8.com/highlight/detail?id=2638563758","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2638563758?lang=zh_cn&edition=full","pubTime":"2026-05-26 08:02","pubTimestamp":1779753723,"startTime":"0","endTime":"0","summary":"证券之星消息，5月25日，创新药ETF银华基金（159992）跌1.28%，成交额6.5亿元。当日份额减少了1.12亿份，最新份额为190.46亿份，近20个交易日份额增加5.72亿份。当日资金净流出2.59亿元（资金流向是当日计算的资产净值和上一交易日计算的资产净值相减得出的），最新资产净值计算值为146.84亿元。创新药ETF银华基金跟踪标的为中证创新药产业指数，成立（2020-03-20）以来超额回报为-6.91%，近一个月超额回报为0.1%，管理人为银华基金公司，基金经理为马君 王帅。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026052600004843.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["159316"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637366330","title":"【ETF动向】5月21日港股通创新药ETF汇添富基金涨2.24%，份额减少1.88亿份","url":"https://stock-news.laohu8.com/highlight/detail?id=2637366330","media":"中金财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2637366330?lang=zh_cn&edition=full","pubTime":"2026-05-22 08:48","pubTimestamp":1779410900,"startTime":"0","endTime":"0","summary":"证券之星消息，5月21日，港股通创新药ETF汇添富基金(159570)涨2.24%，成交额28.33亿元。当日份额减少了1.88亿份，最新份额为186.31亿份，近20个交易日份额增加6.13亿份。当日资金净流入1.1亿元(资金流向是当日计算的资产净值和上一交易日计算的资产净值相减得出的)，最新资产净值计算值为265.75亿元。港股通创新药ETF汇添富基金跟踪标的为国证港股通创新药指数，成立(2023-12-28)以来超额回报为-3.97%，近一个月超额回报为1.4%，管理人为汇添富基金公司，基金经理为乐无穹。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushiyaowen/20260522/32245715.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["FDN","VXUS","BK4588","159316","BK4550","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637365479","title":"【ETF动向】5月21日港股通创新药ETF汇添富基金涨2.24%，份额减少1.88亿份","url":"https://stock-news.laohu8.com/highlight/detail?id=2637365479","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2637365479?lang=zh_cn&edition=full","pubTime":"2026-05-22 08:31","pubTimestamp":1779409900,"startTime":"0","endTime":"0","summary":"证券之星消息，5月21日，港股通创新药ETF汇添富基金（159570）涨2.24%，成交额28.33亿元。当日份额减少了1.88亿份，最新份额为186.31亿份，近20个交易日份额增加6.13亿份。当日资金净流入1.1亿元（资金流向是当日计算的资产净值和上一交易日计算的资产净值相减得出的），最新资产净值计算值为265.75亿元。港股通创新药ETF汇添富基金跟踪标的为国证港股通创新药指数，成立（2023-12-28）以来超额回报为-3.97%，近一个月超额回报为1.4%，管理人为汇添富基金公司，基金经理为乐无穹。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026052200008402.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["159316"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637872953","title":"【ETF动向】5月20日港股通创新药ETF汇添富基金跌0.93%，份额减少2.82亿份","url":"https://stock-news.laohu8.com/highlight/detail?id=2637872953","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2637872953?lang=zh_cn&edition=full","pubTime":"2026-05-21 08:31","pubTimestamp":1779323508,"startTime":"0","endTime":"0","summary":"证券之星消息，5月20日，港股通创新药ETF汇添富基金（159570）跌0.93%，成交额27.43亿元。当日份额减少了2.82亿份，最新份额为188.19亿份，近20个交易日份额增加8.5亿份。当日资金净流出3.74亿元（资金流向是当日计算的资产净值和上一交易日计算的资产净值相减得出的），最新资产净值计算值为264.65亿元。港股通创新药ETF汇添富基金跟踪标的为国证港股通创新药指数，成立（2023-12-28）以来超额回报为-3.84%，近一个月超额回报为1.38%，管理人为汇添富基金公司，基金经理为乐无穹。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026052100008376.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["159316"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636894763","title":"创新药继续筑底，华宝基金药ETF、港股通创新药ETF再探历史新低！“抄底”资金狂涌，520880近10日吸金7.7亿","url":"https://stock-news.laohu8.com/highlight/detail?id=2636894763","media":"新浪基金","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2636894763?lang=zh_cn&edition=full","pubTime":"2026-05-20 11:03","pubTimestamp":1779246180,"startTime":"0","endTime":"0","summary":"5月20日，AH创新药再度走低，重仓A股创新药的药ETF华宝、100%创新药研发标的——港股通创新药ETF华宝场内价格再刷历史新低。港股通创新药ETF华宝跌逾1.5%，持续溢价交易。 场内价格迭创新低之际，520880迎来资金密集增仓。截至上日，520880近10日内有9日吸金，金额合计超7.7亿元，最新份额升至58.9亿份新高。自去年9月中旬进入阶段调整期，截至5月19日，港股通创新药ETF华宝标的指数区间累计跌幅超过30%，调整充分，估值风险释放到位。","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/money/fund/jjh/2026-05-20/doc-inhyphnk2640560.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["06978","BK1574","BK4585","159316","520880","159992","FDN","BK4550","BK1161","BK4588","VXUS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636389358","title":"【ETF动向】5月19日港股通创新药ETF汇添富基金跌0.07%，份额减少3.08亿份","url":"https://stock-news.laohu8.com/highlight/detail?id=2636389358","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2636389358?lang=zh_cn&edition=full","pubTime":"2026-05-20 08:02","pubTimestamp":1779235353,"startTime":"0","endTime":"0","summary":"证券之星消息，5月19日，港股通创新药ETF汇添富基金（159570）跌0.07%，成交额27.04亿元。当日份额减少了3.08亿份，最新份额为191.01亿份，近20个交易日份额增加16.36亿份。当日资金净流出6.52亿元（资金流向是当日计算的资产净值和上一交易日计算的资产净值相减得出的），最新资产净值计算值为268.38亿元。港股通创新药ETF汇添富基金跟踪标的为国证港股通创新药指数，成立（2023-12-28）以来超额回报为-3.96%，近一个月超额回报为1.27%，管理人为汇添富基金公司，基金经理为乐无穹。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026052000007976.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["159316"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636400070","title":"【ETF动向】5月18日港股通创新药ETF汇添富基金跌2.64%，份额减少1.29亿份","url":"https://stock-news.laohu8.com/highlight/detail?id=2636400070","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2636400070?lang=zh_cn&edition=full","pubTime":"2026-05-19 08:31","pubTimestamp":1779150695,"startTime":"0","endTime":"0","summary":"证券之星消息，5月18日，港股通创新药ETF汇添富基金（159570）跌2.64%，成交额20.31亿元。当日份额减少了1.29亿份，最新份额为194.09亿份，近20个交易日份额增加23.93亿份。当日资金净流出10.19亿元（资金流向是当日计算的资产净值和上一交易日计算的资产净值相减得出的），最新资产净值计算值为274.9亿元。港股通创新药ETF汇添富基金跟踪标的为国证港股通创新药指数，成立（2023-12-28）以来超额回报为-3.76%，近一个月超额回报为1.41%，管理人为汇添富基金公司，基金经理为乐无穹。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026051900008477.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["159316"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635608930","title":"医药赛道震荡调整，资金逆势布局，港股通创新药ETF易方达（159316）全天净申购超1亿份","url":"https://stock-news.laohu8.com/highlight/detail?id=2635608930","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2635608930?lang=zh_cn&edition=full","pubTime":"2026-05-15 19:28","pubTimestamp":1778844480,"startTime":"0","endTime":"0","summary":"5月15日，医药赛道震荡调整，创新药、生物科技板块跌幅居前，截至收盘，中证创新药产业指数下跌0.9%，恒生港股通创新药指数下跌2.9%，资金逆势布局，港股通创新药ETF易方达全天净申购超1亿份。兴业证券表示，中国创新药具备高效率、低成本的开发优势，在热门技术赛道如ADC、双抗、小核酸等具备竞争优势，有望持续展现行业竞争力。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://fund.stockstar.com/SS2026051500037585.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["159316","516080","BK1515","BK1574","09939","159938","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635278144","title":"创新药板块震荡下挫，港股通创新药ETF易方达（159316）逆势获5000万份净申购","url":"https://stock-news.laohu8.com/highlight/detail?id=2635278144","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2635278144?lang=zh_cn&edition=full","pubTime":"2026-05-13 19:50","pubTimestamp":1778673024,"startTime":"0","endTime":"0","summary":"5月13日，创新药赛道震荡下挫，截至收盘，恒生港股通创新药指数下跌1.9%，中证创新药产业指数下跌1.3%，资金逆势布局，港股通创新药ETF易方达全天净申购达5000万份。兴业证券表示，中国创新药具备高效率、低成本的开发优势，在热门技术赛道如 ADC、双抗、小核酸等具备竞争优势，有望持续展现行业竞争力。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://fund.stockstar.com/SS2026051300039856.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["159316","159992","BK1574","06978","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629204554","title":"创新药赛道走势分化，港股通创新药ETF易方达（159316）全天净申购超1亿份","url":"https://stock-news.laohu8.com/highlight/detail?id=2629204554","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2629204554?lang=zh_cn&edition=full","pubTime":"2026-04-22 19:45","pubTimestamp":1776858351,"startTime":"0","endTime":"0","summary":"4月22日，受市场影响，创新药赛道走势分化，港股创新药板块冲高回落低位震荡，A股创新药板块低开高走，截至收盘，恒生港股通创新药指数下跌0.6%，中证创新药产业指数上涨0.8%，资金逆势布局，港股通创新药ETF易方达(159316，联接基金A/C：024328/024329)全天净申购超1亿份。招银国际指出，生物医药产业定位跃升为新兴支柱产业，预示全链条政策红利将持续释放，AI制药技术突破与中国创新药出海BD爆发形成双重共振，行业基本面有望加速向好。当前国产创新药出海合作已从单一管线授权升级至平台层面合作，跨国药企对中国医药研发实力的认可度正系统性提升。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://fund.stockstar.com/SS2026042200048504.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["06978","BK1161","BK1574","159316","159992"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2628122206","title":"创新药赛道大幅回调，港股通创新药ETF易方达（159316）半日净申购近8000万份","url":"https://stock-news.laohu8.com/highlight/detail?id=2628122206","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2628122206?lang=zh_cn&edition=full","pubTime":"2026-04-17 13:14","pubTimestamp":1776402893,"startTime":"0","endTime":"0","summary":"4月17日早盘，市场低位震荡，创新药赛道大幅回调，指数层面，恒生港股通创新药指数下跌2.4%，中证创新药产业指数下跌2.9%，港股通创新药ETF易方达半日净申购近8000万份。港股通创新药ETF易方达跟踪的恒生港股通创新药指数在编制方案中明确剔除CXO公司，100%聚焦创新药核心企业，Wind数据显示，该产品管理费率为同类中最低一档的0.15%/年，可助力投资者低成本把握创新药商业化提速机遇。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://fund.stockstar.com/SS2026041700022579.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["159316","BK1574","BK1161","06978","159992"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627245839","title":"创新药赛道低位整理，港股通创新药ETF易方达（159316）今日净申购达3400万份","url":"https://stock-news.laohu8.com/highlight/detail?id=2627245839","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2627245839?lang=zh_cn&edition=full","pubTime":"2026-04-13 20:05","pubTimestamp":1776081908,"startTime":"0","endTime":"0","summary":"4月13日，创新药赛道低位整理，指数层面，恒生港股通创新药指数下跌1.2%，中证创新药产业指数下跌0.6%，港股通创新药ETF易方达(159316，联接基金A/C：024328/024329)全天获3400万份净申购。中国银河证券指出，当前创新药板块的调整更多是受技术性回调与情绪因素所致，估值底部已基本明确。2026年，创新药板块或呈现明显的结构性分化，具备核心管线临床数据兑现能力和大额商务拓展交易支撑的龙头企业将更具确定性。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://fund.stockstar.com/SS2026041300029668.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["159992","BK1161","06978","BK1574","159316"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2626194044","title":"创新药赛道小幅反弹，港股通创新药ETF易方达（159316）今日净申购达1700万份","url":"https://stock-news.laohu8.com/highlight/detail?id=2626194044","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2626194044?lang=zh_cn&edition=full","pubTime":"2026-04-10 19:24","pubTimestamp":1775820298,"startTime":"0","endTime":"0","summary":"4月10日，创新药赛道小幅反弹，指数层面，恒生港股通创新药指数、中证创新药产业指数均上涨0.5%，港股通创新药ETF易方达(159316，联接基金A/C：024328/024329)全天获1700万份净申购。招银国际指出，生物医药产业定位跃升为新兴支柱产业，预示全链条政策红利将持续释放，AI制药技术突破与中国创新药出海BD爆发形成双重共振，行业基本面有望加速向好。当前国产创新药出海合作已从单一管线授权升级至平台层面合作，跨国药企对中国医药研发实力的认可度正系统性提升。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://fund.stockstar.com/SS2026041000035247.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1161","BK1574","159992","06978","159316"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2626908157","title":"创新药赛道早盘下挫，港股通创新药ETF易方达（159316）逆势获近3000万份净申购","url":"https://stock-news.laohu8.com/highlight/detail?id=2626908157","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2626908157?lang=zh_cn&edition=full","pubTime":"2026-04-09 13:07","pubTimestamp":1775711253,"startTime":"0","endTime":"0","summary":"4月9日早盘，创新药赛道小幅下挫，指数层面，恒生港股通创新药指数下跌0.7%，中证创新药产业指数下跌1.0%，港股通创新药ETF易方达(159316，联接基金A/C：024328/024329)逆势获近3000万份净申购。消息面上，2026年美国癌症研究协会(AACR)年会将于4月17日至22日召开，这是全球肿瘤创新药最重要的数据发布窗口之一。今年共有104家中国药企参会，展示超250款创新药物及近400项前沿研究成果，其中92款为ADC药物，覆盖HER2、Trop2等热门靶点，另有66款小分子及核药、细胞治疗等前沿技术成果同步披露。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://fund.stockstar.com/SS2026040900018213.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["159316","06978","BK1574","159992","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2619719965","title":"医药板块周线回调，关注港股通创新药ETF易方达（159316）、创新药ETF易方达（516080）等产品布局机会","url":"https://stock-news.laohu8.com/highlight/detail?id=2619719965","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2619719965?lang=zh_cn&edition=full","pubTime":"2026-03-13 18:55","pubTimestamp":1773399353,"startTime":"0","endTime":"0","summary":"本周，中证创新药产业指数下跌0.8%，沪深300医药卫生指数下跌1.0%，中证生物科技主题指数下跌1.1%，恒生港股通创新药指数下跌3.0%，中证港股通医药卫生综合指数下跌3.4%。Wind数据显示，截至昨日，港股通创新药ETF易方达(159316，联接基金A/C：024328/024329)和创新药ETF易方达(516080，联接基金A/C：019666/019667)本周分别获3600万元和2100万元资金净流入。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://fund.stockstar.com/SS2026031300033395.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["159938","159316","516080","09939","BK1574","BK1515","BK1161","520880"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1779854480064,"stockEarnings":[{"period":"1week","weight":-0.0106},{"period":"1month","weight":-0.1349},{"period":"3month","weight":-0.1442},{"period":"6month","weight":-0.2298},{"period":"1year","weight":0.0548},{"period":"ytd","weight":-0.1122}],"compareEarnings":[{"period":"1week","weight":-0.0058},{"period":"1month","weight":0.016},{"period":"3month","weight":-0.0004},{"period":"6month","weight":0.0697},{"period":"1year","weight":0.2386},{"period":"ytd","weight":0.0445}],"compareStock":{"symbol":"000001.SH","name":"上证指数"}},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.42.2","shortVersion":"4.42.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"创新药E(159316)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供创新药E(159316)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"创新药E,159316,创新药E股票,创新药E股票老虎,创新药E股票老虎国际,创新药E行情,创新药E股票行情,创新药E股价,创新药E股市,创新药E股票价格,创新药E股票交易,创新药E股票购买,创新药E股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"创新药E(159316)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供创新药E(159316)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}